N Engl J Med 345(12):851860 Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-H et al (2001Effects) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Int J Radiat Oncol Biol Phys 18:10691075
Maybe you or someone you know uses special treatments to battle cancer
10.1016/j.mefs.2017.07.003 116
Biomarker assessmentincluding baseline GLP-1 levels, insulin sensitivity, lipid metabolism markers, and genetic predispositionsmay help providers tailor initial expectations and dosing strategies
The dosages may be adjusted over time, and the patients response to the medication is closely monitored to achieve the best possible outcomes, with the goal of reaching a maintenance dose that supports long-term weight management success